Search
English

Biod Selected in a Market Where 95% of AI Drug Pilots Fail(venturesquare.net)

1 vote mrlatte Discuss

Writing language: KoreanRead in the original language

Plain summary

- Biod was selected for the Ministry of SMEs and Startups' 'Super Gap 1000+' program, securing up to 600 million KRW in funding. - It is welcome news for early-stage bio teams because they can continue research without giving up equity. - By deciding which tasks in drug development to improve and which experiments to finish before the funding runs out, the content to show to the next investor becomes much clearer.

Read source ↗

Have you run into something like this? Tell us in a line or two what you did. You do not need to know the product.

Sign in to comment

Keyboard shortcuts

Choose a post with J and K or the arrow keys, then press Enter.

K ↑ / J ↓
Previous post / next post
Enter C
Open summary and comments for the selected post
O
Open the original link of the selected post
/
Search
?
Show this help
Tab
Move to the submit or comment button, then press Enter

Type normally in text fields. Tab and Enter are always available.